Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
26.64
+0.48 (1.83%)
Aug 27, 2026, 10:47 AM EDT - Market open
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $4.25 billion as of August 27, 2026. Its market cap has increased by 118.13% in one year.
Market Cap
4.25B
Enterprise Value
4.29B
1-Year Change
118.13%
Ranking
Category
Stock Price
$26.64
ChartMarket Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $4.25B, a decrease of -10.95%. That is a compound annual growth rate of -1.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 4.25B | 71.49% |
| Dec 31, 2025 | 2.48B | 180.23% |
| Dec 31, 2024 | 884.74M | 24.72% |
| Dec 29, 2023 | 709.39M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Twist Bioscience | 9.50B |
| Qiagen | 9.03B |
| RadNet | 6.05B |
| Sotera Health Company | 5.57B |
| BillionToOne | 4.72B |
| GRAIL | 3.69B |
| Veracyte | 3.54B |
| CareDx | 2.63B |